MedTrace Logo

Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis

NCT02572700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-03-05

No results posted yet for this study

Summary

The objective of the study is to investigate pain mechanisms, comorbidity status, biomarkers, patient reported outcome measures, ultrasonographic (US) inflammatory activity and association between these features in patients with psoriatic arthritis (PsA) intensifying anti-rheumatic treatment. Furthermore, to assess the predictive value of baseline pain profile, comorbidity status, and US joint/entheses activity on treatment outcome after 4 months. Finally, we aimed to compare baseline characteristics with I) patients with skin psoriasis without arthritis and II) healthy controls.

Conditions

Interventions

OTHER

Clinical examination, blood sampling, ultrasonic assessment, and questionnaires

Visits include clinical examination, questionnaires (pain, comorbidity, lifestyle, work status) and ultrasonography of joints and entheses, blood samples, and only at baseline x-ray of hands and feet.

Sponsors & Collaborators

  • Frederiksberg University Hospital

    lead OTHER

Principal Investigators

  • Lars Erik Kristensen, MD, Ph.D · The Parker Institute, Frederiksberg and Bispebjerg Hospital, Frederiksberg, Denmark

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572700 on ClinicalTrials.gov